Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis

Journal:

Journal of Hepatology

Published:

2025-08-21

DOI:

10.1016/j.jhep.2025.08.005

Affiliations:

27

Authors:

36

Go to article

Institutions	Authors	Share
Institute for Translational Medicine and Liver Disease (ITM), France	11.333333 11.333333	0.31
University of Toronto (U of T), Canada	3.500000	0.10
Ajmera Transplant Centre, Canada	3.500000	0.10
University Hospitals Leuven (UZ Leuven), Belgium	3.500000	0.10
Oslo University Hospital (OUS), Norway	3.000000	0.08
University of Nebraska Medical Center (UNMC), United States of America (USA)	2.000000	0.06
Alentis Therapeutics AG, Switzerland	2.000000	0.06
University of Milano-Bicocca (UNIMIB), Italy	1.500000	0.04
ERN RARE-LIVER, Italy, Italy	1.000000	0.03
San Gerardo Hospital, Italy	1.000000	0.03
Catholic University of Leuven (KU Leuven), Belgium	0.500000	0.01
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany	0.500000	0.01
University Hospital Tübingen (UKT), Uni Tübingen, Germany	0.500000	0.01
Niguarda Hospital, Italy	0.500000	0.01
Strasbourg University Hospital Institute (IHU Strasbourg), France	0.333333	0.01
University Institute of France (IUF), France	0.333333	0.01
Biogipuzkoa Health Research Institute (IIS Biogipuzkoa ), Spain	0.200000	0.01
Donostia University Hospital, Spain	0.200000	0.01
University of the Basque Country (UPV/EHU), Spain	0.200000	0.01
Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBEREHD), Spain	0.200000	0.01
University of Navarra (UNAV), Spain	0.200000	0.01

Interested in Medical Biochemistry and Metabolomics?